Condition

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

ClinicalTrials.gov condition label

Clinical trials9

Recruiting4

Common interventions6

Lead sponsors shown8

Clinical trials

9 shown

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)NCT06474520 · 2024-08-08

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.NCT06280755 · 2024-03-01

Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating DiseasesNCT06541626 · 2024-01-01

MS-ResearchBiomarkerSNCT05204459 · 2021-11-11

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune DiseaseNCT07804004 · 2026-09-15

NOT_YET_RECRUITING

Tongji NADs CohortNCT07333196 · 2026-03-01

NOT_YET_RECRUITING

National, Multicentric Registry Study on Neuroimmunological Diseases in ChinaNCT06443333 · 2020-12-01

Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic NerveNCT05605951 · 2020-08-15

The Italian Multiple Sclerosis and Related Disorders RegisterNCT07636876 · 2014-09-17

ENROLLING_BY_INVITATION

Common interventions

Calculus bovis sativus (CBS)DRUG1 CTX112BIOLOGICAL1 Data collectionOTHER1 Data collection and follow-up observationOTHER1 No active interventionsOTHER1 non-interventional studyOTHER1

Leading sponsors

Tongji Hospital2 Cedars-Sinai Medical Center1 CRISPR Therapeutics1 Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul1 Fondazione Italiana Sclerosi Multipla1 icometrix1 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 Xuanwu Hospital, Beijing1

Trial status mix

RECRUITING4

NOT_YET_RECRUITING2

UNKNOWN2

ENROLLING_BY_INVITATION1

Phase mix

NA1

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.